查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球医用仿生植入物市场-2022-2029
市场调查报告书
商品编码
1140710

全球医用仿生植入物市场-2022-2029

Global Medical Bionic Implant Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场概览

预计 2021 年医用仿生植入物市场规模将达到 237.36 亿美元，2029 年将达到 415.89 亿美元，在预测期间（2022-2029 年）的复合年增长率为 8.7%。预计。

仿生学是生物学和电子学的结合。它是将一种特殊类型的装置或假体植入人体，以再现原始器官的功能。医学仿生学通过自动适应来替换或改善身体的不同部位。先进的仿生植入物提供优于传统假肢的优势，包括减少疲劳和不适以及实时控制。医用仿生植入物被归类为假器官，因为它们完美地模仿了自己的能力或表现出超越它们的改进。

市场动态

不断增长的需求推动市场增长，交通事故增加，老年人口增加，个人慢性病数量增加，器官衰竭，伤害和事故数量增加，以及对医学仿生学的需求。职业残疾可以改善问题.

医疗技术的不断进步和慢性病患病率的上升预计将推动市场的增长。

医疗技术的不断进步正在推动医疗仿生植入物市场的发展。此外，公众对各种疾病的认识不断提高，医用仿生植入物和人工器官手术的进步，以及对各种疾病进行早期诊断和治疗的筛查需求，也推动了医用仿生植入物市场的发展。

此外，世界各地许多人患有糖尿病和外周动脉疾病等血管疾病，增加了截肢的可能性。在美国，据说大约有 200 万人患有截肢者。根据美国国家卫生统计中心的数据，美国每年进行 185,000 次截肢手术，据估计，目前该国约有 200 万人与截肢者一起生活。医用仿生植入物和市场的快速发展导致了新机器人技术的开发和改进。医疗器械製造商之所以转向新兴市场，主要是因为它们的人口众多以及对仿生替代品的持续需求。

此外，越来越多的截肢手术加上高科技生物材料植入物的功能不断增加，也促进了医用仿生植入物和外骨骼市场的增长。这些因素正在推动医用仿生植入物市场的增长。

仿生手臂的发展将刺激市场的增长。 2020 年 2 月，作为仿生手臂假肢开发的下一个里程碑，维也纳医科大学与麻省理工学院（Extreme Bionics Center）和维也纳大学电气工程系合作哥德堡，维也纳医科大学外科奥斯卡阿斯曼团队在肢体重建临床实验室的仿生开发了世界上第一个完全集成的仿生手臂假肢，可以使用。第一次，系统是独立的，一切都直接发生在你的手臂上。电池直接插入假肢，晚上可以轻鬆取出和充电。

由于医疗领域的快速技术进步以及对医用仿生植入物和人造器官的需求不断增长，预计全球医用仿生植入物市场将在预测期内强劲发展。

此外，仿生学的概念已被应用到其他领域，例如用于建造士兵穿戴的外骨骼的防御。这种外骨骼和仿生服可以帮助士兵携带重物并提高他们在战场上的机动性。仿生设备正在开发中，其功能范围从解剖学上正确的印刷假肢和美容细节到智能手机控制命令。

预计不断上涨的医疗成本和设备故障将阻碍市场增长。

高昂的治疗成本、昂贵的设备、故障设备、有限的手术专业知识以及因地区而异的不确定报销方案等因素阻碍了市场增长。

行业分析

全球医用仿生植入物市场根据包括波特五力、监管分析、供应链分析和定价分析在内的各种行业因素对市场进行了深入分析。

细分分析

心臟仿生部分有望在全球医用仿生植入物市场中占据最大市场份额

医疗仿生植入物市场根据视觉仿生、心臟仿生、骨科仿生、耳仿生、脑仿生等进行细分。其中，由于心血管疾病的高发病率，心臟仿生学占据了最大的市场份额。预计 Earbionics 将在预测期内占据很大的市场份额。患者更喜欢这些设备，因为它们比药物更容易、更舒适。

骨科仿生学是人体各个部位骨骼的人工替代品或替代品。髋关节、膝关节、肘关节、踝关节、腿等是典型的假肢。根据 2020 年斯坦福儿童健康报告，估计有 350 万运动伤害，这一数字有望成为市场驱动力。 Brain Bionics 是一种专门针对通过将植入物插入人的头部而导致抑郁的错误大脑活动的治疗方法。

此外，从技术角度来看，市场分为植入式和外部可穿戴设备。由于使用量的增加，植入物占据了最高的市场份额。它用于起搏器、RFID 标籤、神经刺激器和许多其他具有无线通信能力的植入物。黑色金属坚固而坚硬，几乎不受极端环境的影响。然而，由于其磁性，应尽量减少暴露于其他磁场。

由于与非技术用户相比，对身体形象的需求不断增加，外部可穿戴设备是一个市场有望增长的领域。在适当的情况下，这些数据可用于识别潜在问题，制定缓解这些问题的策略，并在糖尿病患者考虑采用外部技术时为他们提供信息。

区域分析

北美在全球医用仿生植入物市场中占有最大的市场份额

医用仿生植入物市场按地区划分为北美、南美、欧洲、亚太地区、中东和非洲。由于对技术先进产品的需求以及政府强有力的研发计划和患者的高意识水平，北美等地在医用仿生植入物市场中占据主导地位。此外，北美是众多研究实验室、生物技术公司和医疗器械製造公司的所在地，预计它们将为市场的增长做出贡献。此外，有利的医疗补偿计划和对器官移植的高需求也有望推动北美市场的增长。

由于其庞大的不断增长的消费者基础、政府加强医疗保健的努力以及高可支配收入，预计亚太地区将占据较大的市场份额。印度和中国的快速发展以及患者意识水平的提高是该地区增长的主要驱动力。几个国家的政府和监管机构正在采取协调一致的措施，以确保医疗仿生植入物市场的持续需求。世界银行表示，亚太地区国家的外国直接投资显着增加。马来西亚、印度尼西亚和印度等新兴市场的经济增长率远高于发达国家。因此，预计这些国家将在医疗保健领域进行更多投资，从而振兴全球医用仿生植入物市场。

竞争格局

许多来自日本和国外的公司已进入市场。技术进步、新产品发布和具有成本效益的解决方案增加了市场竞争。 Orthofix International N.V.、Touch Bionics Inc、Second Sight Medical Products, Inc、Ekso Bionics、St. Jude Medical, Inc、Lifenet Health Inc 和 Otto Bock Inc 是市场份额较大的主要参与者。

公司专注于开发和升级现有机器，以提高年生产率并优化加工操作流程。例如，2019 年科利耳推出了世界上第一个有源骨整合固定植入物 Osia。它使用数字压电刺激将声音振动直接传递到耳蜗，绕过听觉系统的受损区域。

公司正在开展研究合作、合併、战略合作伙伴关係和收购，以增加对生物标誌物的需求并在全球范围内扩张。例如，2020 年 6 月，专注于肌肉骨骼癒合产品的全球医疗器械公司 Orthofix Medical Inc. 宣布获得美国食品药品监督管理局（Food and Drug Administration）的批准和第一个患者植入物 FIREBIRD SI Fusion System。 FIREBIRD SI Fusion System 是美国发布的第一款 3D 打印钛合金 SI 关节骨螺钉，旨在压缩和稳定□髂关节（SI 关节）。 FIREBIRD SI 融合系统设计有一个多孔的中心轴，骨骼在其上生长，在 SI 关节处在植入物和患者骨骼之间建立结合。

值得关注的重点公司

Ekso Bionics Holdings Inc：

概述 Ekso Bionics 是一种动力外骨骼，可用作可穿戴机器人，以提高瘫痪患者以及中风或严重受伤后行动不便的人的耐力、运动能力和力量。一家开发 nick 设备的仿生设备公司。成立于2005年，总部位于美国加利福尼亚州。

按产品类型划分的产品组合

Ekso EVO：一种支持上半身的外骨骼，可增加耐力并减轻繁重任务的压力。建立在 EksoVest 技术之上。

重大进展。 2020 年 6 月，Ekso Bionics 控股公司宣布美国 FDA 批准 EksoNR 用于创伤性脑损伤患者。

全球医用仿生植入物市场报告提供大约 45 多个市场数据表、40 多个数字和 180 页。

内容

第1章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

第 4 章市场动态

  • 市场影响因素
    • 驱动程序
      • 慢性病发病率增加
      • 医疗技术的进步
    • 限制因素
      • 治疗费用飙升
      • 设备故障
    • 商机
    • 影响分析

第五章行业分析

  • 波特五力分析
  • 监管分析
  • 供应链分析
  • 定价分析

第 6 章按产品类型分析

  • 视觉仿生学
  • 心臟仿生学
    • 辅助人工心臟
    • 全人工心臟
    • 人工心臟瓣膜
    • 起搏器
  • 用于骨科手术的仿生学
    • 仿生手
    • 仿生腿
    • 仿生肢体
  • 耳仿生学
    • 骨传导助听器
    • 人工耳蜗
  • 脑仿生学
    • 深部脑刺激器
    • 迷走神经刺激器
    • 脊髓刺激器
  • 其他

第 7 章按技术分类

  • 机械
  • 电子

第8章固定方法

  • 种植体类型
  • 外戴型

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 主要发展和战略
  • 公司份额分析
  • 按产品类型进行基准测试
  • 值得关注的重点公司列表

第 11 章公司简介

  • Ekso Bionics Holdings, Inc.
  • Touch Bionics Inc.
  • 生命网健康股份有限公司
  • 爱德华兹生命科学有限公司
  • Orthofix Holdings, Inc.
  • Livanova PLC
  • 彩虹医疗集团
  • 波士顿科学公司

第 12 章全球医用仿生植入物市场-DataM

简介目录
Product Code: DMMD2573

Market Overview

Medical Bionic Implant Market size was valued US$ 23,736 million in 2021 and is estimated to reach US$ 41,589 million by 2029, growing at a CAGR of 8.7% during the forecast period (2022-2029).

Bionics incorporates biology with electronics. It implants the special types of instruments or prosthetics that have been inserted into the human body to replicate the original organ function. Medical Bionics replaces or improves different parts of the body with automated adaptations. Advanced bionic implants have advantages over traditional prostheses, such as less tiredness, discomfort, and control in real-time. Medical bionic implants are assorted from the counterfeit organ as they mimic unique capacity completely or even show improvement over it.

Market Dynamics

The rising demand drives the market growth, increasing road accidents, growing geriatric population, rising number of chronic diseases among individuals, organ failure, increasing injuries and accidents, and occupational disabilities that demand medical bionic improve the problem.

Growing advancements in medical technologies and rising prevalence of chronic diseases are expected to drive market growth.

Growing advancements in medical technologies are fueling the medical bionic implant market. Growing public awareness about various diseases, advancements in medical bionic implant and artificial organ procedures, and the need for screenings conducted for early diagnosis and treatment of various diseases are also expected to favor the medical bionic implant market.

Moreover, people worldwide suffer from vascular diseases, including diabetes and peripheral arterial diseases, which increase the chances of amputations. In the U.S., there are about two million people who are living with limb loss. As per data from the National Center for Health Statistics, 185,000 amputations are conducted in the U.S. every year, and roughly 2 million people in the country are currently living with a lost limb. Rapid advancements in the medical bionic implants and market have led to new and improved robotics technology. Medical device makers are looking at emerging economies mainly because of their large populations and continued demand for bionic replacements.

Besides, a greater number of amputations coupled with improved capabilities of high-tech biomaterial-based implants contribute to the growth of the medical bionic implants and exoskeletons market. These factors are driving the growth of the medical bionic implant market.

The development of bionic arms shall stimulate market growth. In February 2020, the next milestone in the development of bionic arm prostheses with a major contribution from the Medical University of Vienna, in collaboration with the Massachusetts Institute of Technology (Center for Extreme Bionics) and the Department of electrical engineering at the University of Gothenburg, Oskar Aszmann's team in the clinical laboratory for bionic limb reconstruction at Meduni Vienna's department of surgery has developed the world's first fully-integrated bionic arm prosthesis that is ready to use. For the first time, this system is self-contained, and everything takes place directly in the arm. The battery inserts directly into the prosthesis and can easily be removed in the evening for recharging.

With quick technological advancement, rapid technological advancements in the medical field, the ever-increasing demand for medical bionics implants and artificial organs, the global medical bionic implant market is anticipated to develop during the forecast period vigorously.

Moreover, the concept of bionics is applied in other fields, such as the defense to build exoskeletons, which soldiers can wear. These exoskeleton suits or bionic suits help them carry heavy loads and improve their mobility on the battlefield. Bionic devices are being developed with various features such as printed prostheses with anatomically correct shapes along with cosmetic details and smartphone-controlled commands.

High cost of treatment and malfunction of device are expected to hamper the market growth.

The market is hindered by factors such as high cost of treatment, expensive devices, malfunction of devices, limited surgical expertise, and uncertain reimbursement scenarios in different regions are restraining the market's growth.

Industry Analysis

The global medical bionic implant market provides in-depth analysis of the market based on various industry factors such as porter's five forces, regulatory analysis, supply chain analysis, pricing analysis.

Segment Analysis

Heart bionics segment is expected to hold the largest market share in global medical bionic implant market

Medical bionic implant market is segmented based on vision bionics, heart bionics, orthopedic bionics, ear bionics, brain bionics, etc. Among these, heart bionics held the largest market share due to the high prevalence of cardiovascular disorders. Ear bionics are expected to gain substantial market share during the forecast period. These devices are preferred more by the patients owing to the ease and comfort they provide than drugs.

Orthopedic bionics an artificial replacement or substitute of bones in different parts of the body. The typical orthopedic prosthetic devices are for the hip, knee, elbow, ankle, and leg. According to Stanford Children's Health 2020, there were an estimated 3.5 million sports injuries occurred; this significant number is expected to act as a driver to the market growth. Brain bionics are involved in inserting an implant inside a person's head to specifically target faulty brain activity associated with making a person stay "stuck" in their depression.

Further, the market is also classified based on technology as Implantable and Externally Worn. The Implantable segment accounts for the highest market share due to the rising usage. These materials are used pacemakers, RFID tags, neurostimulators, and various other implants with wireless communication functions. The robust and rigid nature of ferrous metals leaves them nearly unaffected by extreme elements. However, their magnetic properties mean exposure to other magnetic fields must be minimized.

The Externally Worn segment is expected to have positive market growth due to the rising demand for body image compared to nontechnology users. Where appropriate, these data can be used to identify potential concerns, address strategies to mitigate them and inform people with diabetes when considering adopting external technologies.

Geographical Analysis

North America region holds the largest market share in the global medical bionic implant market

The medical bionic implant market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa based on the region. Among all of the regions, North America dominated the medical bionic implant market due to the demand for technologically advanced products coupled with strong R&D initiatives by the government and high patient awareness levels. Moreover, many research laboratories, biotechnology, and medical devices manufacturing companies in North America are projected to contribute to its growth. Also, the favorable healthcare compensation plans and high demand for organ transplantation are expected to propel the market's growth in North America.

The Asia Pacific is expected to have a significant market share due to the rising to a large consumer base, rising government initiatives for enhancing healthcare, and high disposable income. Rapidly developing India and China regions and growing patient awareness levels in this region are the major factors contributing to this region's growth. In several countries, national governments and regulatory bodies take collaborative measures to ensure a constant demand for the medical bionic implants market. The World Bank states that countries in the Asia-Pacific region have witnessed a marked rise in FDI. Emerging markets such as Malaysia, Indonesia, and India have recorded much higher economic growth rates than developed nations. This is expected to drive higher investment across the healthcare sector in all of these countries, boosting the global medical bionic implant market.

Competitive Landscape

Several local and international players are present in the market. The technological advancement, new product launches, availability of cost-effective solutions intensify the market competition. Orthofix International N.V., Touch Bionics Inc., Second Sight Medical Products, Inc., Ekso Bionics, St. Jude Medical, Inc., Lifenet Health Inc., and Otto Bock Inc. are the leading market players with significant market share.

Companies focus on developing and upgrading existing machinery to increase annual productivity and optimize processing operational flow. For instance, In 2019, Cochlear announced world's 1st active osseo-integrated steady state implant, Osia. It utilizes digital piezoelectric stimulation that bypass the damaged areas of hearing system by which sound vibrations directly reaches to cochlea.

The companies are entering into collaborations, mergers, strategic partnerships, and acquisitions to increase the demand for biomarkers and their expansion across the globe. For instance, in June 2020, Orthofix Medical Inc., a global medical device company focused on musculoskeletal healing products, announced the U.S. Food and Drug Administration clearance and the first patient implants FIREBIRD SI Fusion System. Designed to compress and stabilize the sacroiliac joint (also called the SI joint) during fusion, the FIREBIRD SI Fusion System is the first 3D printed titanium bone screw to launch in the U.S. for treating SI joint. The FIREBIRD SI Fusion System is designed with a porous mid-shaft region that allows the bone to grow into its surface - creating a bond between the implant and the patient's bone at the SI joint.

Key Companies to Watch

Ekso Bionics Holdings Inc.:

Overview: Ekso Bionics is a bionic devices company that develops powered exoskeleton bionic devices that can be impoverished as wearable robots to increase the endurance, mobility and strength of people with paralysis and suffering from mobility issues after stroke or serious injury. It was founded in 2005 and is headquartered in California, United States.

Product Type Portfolio:

Ekso EVO: It is an assistive upper body exoskeleton that is endurance boosting and lightens the pressure of monotonous work. It is built on EksoVest technology.

Key Developments: In Jun 2020, Ekso Bionics holdings announced approval for its EksoNR by U.S.FDA to use on traumatic brain injury patients.

The global medical bionic implant market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers:
      • 4.1.1.1. Rising Incidence of Chronic Diseases
      • 4.1.1.2. Increasing medical technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost of treatment
      • 4.1.2.2. Malfunctioning of device
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Regulatory Analysis
  • 5.3 Supply Chain Analysis
  • 5.4 Pricing Analysis

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Vision Bionics
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, USD Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 6.3. Heart Bionics
    • 6.3.1. Ventricular assist device
    • 6.3.2. Total artificial heart
    • 6.3.3. Artificial heart valve
    • 6.3.4. Pacemaker
  • 6.4. Orthopedic Bionics
    • 6.4.1. Bionic hand
    • 6.4.2. Bionic leg
    • 6.4.3. Bionic limb
  • 6.5. Ear Bionics
    • 6.5.1. Bone anchored hearing aid.
    • 6.5.2. Cochlear implant
  • 6.6. Brain Bionics
    • 6.6.1. Deep brain stimulator
    • 6.6.2. Vagus nerve stimulator
    • 6.6.3. Spinal cord stimulator
  • 6.7. Others

7. By Technology

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 7.1.2. Market Attractiveness Index, By Technology
  • 7.2. Mechanical
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, USD Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Electronic

8. By Method of Fixation

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 8.1.2. Market Attractiveness Index, By Method of Fixation
  • 8.2. Implantable
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, USD Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Externally Worn

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 9.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. U.S.
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 9.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. U.K.
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 9.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.6.1. Brazil
      • 9.4.6.2. Argentina
      • 9.4.6.3. Rest of South America
  • 9.5. Asia Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation
    • 9.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Technology
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Method of Fixation

10. Competitive Landscape

  • 10.1. Key Developments and Strategies
  • 10.2. Company Share Analysis
  • 10.3. Product Types Benchmarking
  • 10.4. List of Key Companies to Watch

11. Company Profiles

  • 11.1. Ekso Bionics Holdings, Inc.

a. Company Overview

b. Product Type Portfolio and Description

c. Key Highlights

d. Financial Overview

  • 11.2. Touch Bionics Inc.
  • 11.3. LifeNet Health Inc.
  • 11.4. Edwards Lifesciences Corporation
  • 11.5. Orthofix Holdings, Inc.
  • 11.6. LivaNova PLC
  • 11.7. Rainbow Medical Group
  • 11.8. Boston Scientific Corporation

LIST NOT EXHAUSTIVE

12. Global Medical Bionic Implant Market - DataM

  • 12.1. Appendix
  • 12.2. About Us and Method of Fixation
  • 12.3. Contact Us